NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/09/2024
Back to search
Official data from USPTO
CLINIPRIME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CLINIPRIME
ST13
US500000097533508Class
1, 5
Filing
97533508
Registration
7271459
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
01/09/2024
Trademark type
Word
Nice classes
1, 5
Filing date
08/03/2022
Registration date
01/09/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/09/2024
Last transaction
01/09/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/16/2023
First use in commerce
01/16/2023
Drawing code
4
Owner type
03
Owner location
Wilmington, MA, US
Examiner
TORRES, MIGUEL A
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Charles River Laboratories, Inc.
Representatives
Joseph V. Myers III SEYFARTH SHAW LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological tissuebone marrowcord bloodnormal peripheral bloodmobilized peripheral bloodfor use in scientific and medical research; Cells for scientific and research use; Cells for scientificlaboratory or medical research; Stem cells for research purposes; Biological tissuebloodstem cellsumbilical cords and placentas for scientific and medical research use; Stem cells for research or scientific purposes; Biological tissueblood for scientific or medical research use
Class 5
Cells for medical or clinical use; Solutions for medical and clinical use in storing and treating cellsblood and blood components; Stem cells for medical or veterinary use; Stem cells for medical purposes
Publications
History of USPTO decisions and trademark events.
27 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/09/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/06/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/10/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/10/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/12/2023
GNRT
NON-FINAL ACTION E-MAILED
08/12/2023
CNRT
SU - NON-FINAL ACTION - WRITTEN
08/12/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/12/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/12/2023
IUAF
USE AMENDMENT FILED
06/14/2023
EISU
TEAS STATEMENT OF USE RECEIVED
06/14/2023
DRRR
DIVISIONAL REQUEST RECEIVED
05/23/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/27/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/01/2022
PUBO
PUBLISHED FOR OPPOSITION
11/01/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/12/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/26/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
09/24/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/24/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
09/24/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/24/2022
DOCK
ASSIGNED TO EXAMINER
09/23/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/25/2022
NWAP
NEW APPLICATION ENTERED
08/06/2022
Continuous trademark protection
Get notified about every new filing that threatens CLINIPRIME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.